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D1R/GluN1 complexes in the striatum integrate dopamine
and glutamate signalling to control synaptic plasticity and
cocaine-induced responses
E Cahill1,2,3,9, V Pascoli4,9, P Trifilieff5,6,7, D Savoldi1,2,3, V Kappès1,2,3, C Lüscher4,8, J Caboche1,2,3 and P Vanhoutte1,2,3
Convergent dopamine and glutamate signalling onto the extracellular signal-regulated kinase (ERK) pathway in medium spiny
neurons (MSNs) of the striatum controls psychostimulant-initiated adaptive processes underlying long-lasting behavioural changes.
We hypothesised that the physical proximity of dopamine D1 (D1R) and glutamate NMDA (NMDAR) receptors, achieved through
the formation of D1R/NMDAR complexes, may act as a molecular bridge that controls the synergistic action of dopamine and
glutamate on striatal plasticity and behavioural responses to drugs of abuse. We found that concomitant stimulation of D1R and
NMDAR drove complex formation between endogenous D1R and the GluN1 subunit of NMDAR. Conversely, preventing D1R/GluN1
association with a cell-permeable peptide (TAT-GluN1C1) left individual D1R and NMDAR-dependent signalling intact, but
prevented D1R-mediated facilitation of NMDAR–calcium influx and subsequent ERK activation. Electrophysiological recordings in
striatal slices from mice revealed that D1R/GluN1 complexes control the D1R-dependent enhancement of NMDAR currents and
long-term potentiation in D1R-MSN. Finally, intra-striatal delivery of TAT-GluN1C1 did not affect acute responses to cocaine but
reduced behavioural sensitization. Our findings uncover D1R/GluN1 complexes as a major substrate for the dopamine–glutamate
interaction in MSN that is usurped by addictive drugs to elicit persistent behavioural alterations. They also identify D1R/GluN1
complexes as molecular targets with a therapeutic potential for the vast spectrum of psychiatric diseases associated with an
imbalance between dopamine and glutamate transmission.
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INTRODUCTION
Addiction is a chronic and relapsing psychiatric disorder, thought
to occur in vulnerable individuals due to a perturbation of goal-
directed behaviour.1 The striatum orchestrates motivated beha-
viour such as motor planning and reward-dependent learning.2,3
These functions require the integration, by the medium spiny
neurons (MSNs) of the striatum, of glutamate inputs arising from
the cortex and thalamus together with dopamine (DA) release. It is
widely acknowledged that DA and glutamate systems interact to
control synaptic plasticity in MSN and addiction-related behaviour,
but the underlying molecular mechanisms are still poorly under-
stood. Herein, we hypothesised that, because of their physical
proximity, DA and glutamate receptor complexes play the role of
detectors of coincidence for DA and glutamate signals in the
striatum thereby participating to persistent behavioural adapta-
tions induced by drugs of abuse.
All addictive drugs increase DA in the nucleus accumbens (NAc)
region of the striatum,4 where it modulates glutamate
transmission.5,6 As such, drugs of abuse usurp the neural reward
circuitry and induce molecular events underlying long-lasting
changes in synaptic transmission7 and behaviour.8 Drugs of abuse
also share the ability to activate extracellular signal-regulated
kinase (ERK) in the striatum,9 where it controls gene expression,
long-term synaptic plasticity and behaviour.10 Activation of ERK by
cocaine occurs in dopamine D1 receptor (D1R)-expressing MSN11
(D1R-MSN) and behaves as an integrator of DA and glutamate
signals as it requires the coincident stimulation of D1R and
glutamate NMDA receptors12,13 (NMDAR). We recently established
a pivotal role of the signalling crosstalk between D1R and NMDAR
in cocaine-mediated responses, as D1R stimulation in absence of
glutamate does not trigger ERK activation but can potentiate
NMDAR-dependent calcium influx via the tyrosine phosphoryla-
tion of GluN2B subunits. This interplay between D1R and GluN2B-
NMDAR was necessary for cocaine-induced ERK activation and
long-term behavioural alteration.14 Indeed, a causal connection
between ERK-dependent long-term potentiation (LTP) in the
NAc and behavioural sensitization was recently demonstrated.15
A number of studies have demonstrated that the physical
interaction between D1R and NMDAR subunits was dynamically
regulated by ligands and can mutually modify receptor function,16
thereby increasing the signalling diversity and complexity.
Co-immunoprecipitation, GST-pull down and resonance energy
transfer techniques demonstrated that the D1R C-terminal tail
binds to the GluN1 and GluN2A subunits.17–19 In vivo, uncoupling
the D1R/NMDAR receptor complexes in the hippocampus impairs
NMDA-dependent LTP and working memory.20 The striatum is the
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main target of DA projections in the brain and striatal-dependent
behaviour greatly depends on DA and glutamate crosstalk, yet the
functional role of the D1R/NMDAR interaction for striatal signal-
ling, plasticity and responses to addictive drugs is unknown.
We optimised an interfering peptide-based strategy to selec-
tively disrupt endogenous D1R/GluN1 complexes in neurons. We
found that a TAT-coupled peptide (TAT-GluN1C1), corresponding
to the C1 cassette of GluN1 that binds to the t2 domain of D1R18,19
blocked signalling pathways downstream of D1R/GluN1 com-
plexes, yet preserved individual D1R and NMDAR signalling. TAT-
GluN1C1 blocked D1R-dependent potentiation of calcium influx
through GluN2B-NMDAR along with ERK activation in MSN after a
co-stimulation (co-stim) of D1R and NMDAR, which favoured
endogenous D1R/GluN1 heteromerization. As predicted by ERK
inhibition, TAT-GluN1C1 prevented NMDAR-mediated LTP of
glutamate transmission onto D1R-MSN. In vivo, TAT-GluN1C1
preserved basal locomotor activity and acute responses to
cocaine, but impaired the development of behavioural sensitiza-
tion. Our findings identify D1R/GluN1 complexes as a molecular
bridge by which DA modulates glutamate transmission and
glutamate-dependent plasticity and, eventually, behaviour in
response to cocaine.
MATERIALS AND METHODS
Chemicals and reagents
(R)-(+)-SKF38393 (Sigma Aldrich, St Louis, MO, USA) and/or L-glutamic acid
(Calbiochem, San Diego, CA, USA) were diluted at the indicated concentra-
tions in purified water. When indicated, the following cell-penetrating
peptides were administered 1 h before and during further treatments: TAT-
GluN1C1: GRKKRRQRRRPPDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDT; its
inactive counterpart, the TAT-GluN1C1Δ: GRKKRRQRRRPPDRKSGRAEPDPKK
KATFRAITSTLASDT, TAT-D1-t2: GRKKRRQRRRPPLVYLIPHAVGSSEDLKREEAGGI
PKPLEKL, TAT-D1-t3: GRKKRRQRRRPPSPALSVILDYDTDVSLEKIQPVTHSGQHST
and TAT-GluN1C1min: GRKKRRQRRRPPSFKRRRSSK, (IBPS, Institut de Biologie
Paris - Seine), UMPC, Paris; France). For the in vitro studies, peptides were
administered at a final concentration of 5 μM 1 h prior and during
pharmacological treatments. For in vivo experiments, the peptides were
infused at a concentration of 5 pmol per hemisphere in a volume of 0.5 μl, 1h
before the administration of cocaine. Other pharmacological agents used are
detailed as Supplementary Information.
Proximity ligation assay
Brain slices were prepared as previously described21 and proximity ligation
assay (PLA) was performed using the Duolink in situ kit (Olink Bioscience,
Uppsala, Sweden) according to the manufacturer’s instructions with the
following modifications: PLA probes incubation was for 2 h; ligation was
performed for 45min; amplification step was extended for 2 h with a
concentration of polymerase of 1/60 all at 37°C. Striatal primary cultured
cells were plated into 8-μ well plates (LabTek, Dutscher, Brumath, France).
Blocking (1 h at room temperature) and primary antibody (overnight at 4 °
C) incubations were performed in a 3% bovine serum albumin (Sigma
Aldrich) and 0.2% Triton X-100 solution. Rabbit anti-GluN1 (ab17345,
Abcam, Cambridge, MA, USA) and rat anti-D1R (D2944, Sigma Aldrich)
were diluted (1:500) in the blocking solution. The anti-rabbit (+) PLA probe
(1:5) along with an anti-rat (− ) probe (1:100) were diluted in the blocking
solution. Anti-rat PLA probes were generated according to the manufac-
turer’s instructions using the Duolink Probemaker (Olink Bioscience). Goat-
anti-rat IgGs (Santa Cruz, Heidelberg, Germany) were used. Cells were
mounted in FluorSave (Calbiochem). Image acquisition and quantification
are detailed in the Supplementary Information section.
Electrophysiology
Heterozygous transgenic mice in which tdTomato expression was driven
by D1R (drd1a-tdTomato from Jackson Laboratories, Sacramento, CA, USA)
gene regulatory element or enhanced green fluorescent protein (eGFP)
expression was driven either by D1R (drd1a-eGFP) or D2R (drd2-eGFP) gene
regulatory elements22 were backcrossed in C57Bl/6 mice for 3–4
generations and housed in groups of 3–4 in a temperature- and
hygrometry-controlled environment with a 12/12- h light/dark cycle. All
procedures were approved by the Institutional Animal Care and Use
Committee of the University of Geneva.
Slice preparation and high-frequency stimulation-induced AMPAR-LTP
were performed as described.15 For NMDAR-mediated excitatory post
synaptic currents (EPSCs), the internal solution contained (in mM): 130
cesium chloride, 4 NaCl, 5 sodium creatine-phosphate, 2 MgCl2, 2 Na2ATP,
0.6 Na3GTP, 1.1 EGTA, 5 HEPES, 0.1 spermine (see Supplementary Materials
and Methods for information about pharmacological treatments).
For the LTP experiments, the internal solution contained (in mM): 140
k-gluconate, 5 KCl, 10 HEPES, 0.2 EGTA, 2 MgCl2, 4 Na2ATP, 0.3 Na3GTP and
10 sodium creatine-phosphate. NMDAR-EPSCs were isolated at −70mV by
omitting MgCl2 from the ACSF and adding the AMPAR antagonist. All
experiments were carried out in the presence of picrotoxin (100 μM).
Animals, drugs administration and locomotor sensitization
Male 7-week-old C57BL/6 mice (Janvier laboratories, Le Genest St Isle,
France) were individually housed with ad libitum access to food and water
and maintained on a 12/12 -h light/dark cycle and habituated to the
animal facility for 1 week before experiments. Experiments took place
during the animal’s light cycle. Animal work was carried out in accordance
with the standard ethical guidelines (European Community guidelines on
the care and use of laboratory animals: 2010/63/EU).
Using isofluorane anaesthesia, 22 gauge stainless-steel guide cannulae
(Plastics One, Roanoke, VA, USA) were implanted bilaterally (antero–-
posterior +1.5; medio–lateral ± 1.6; dorso–ventral 4.1; 13° angle) and fixed
with support screws and dental cement (Brudentaire, Paris, France). Mice
recovered during 1 week with daily handling. One hour before intra-
peritoneal cocaine injections (15mg kg− 1; Sigma Aldrich), 5 pmol of cell-
penetrating peptide were bilaterally infused (0.5 μl; 0.2 μl min-1) into
the NAc.
Locomotor activity (1/4 turns) was measured automatically as the
number of crossings between quarters of a circular corridor using ANY-
Maze software (ANY-Maze, Stoeling, Wood Dale, IL, USA) and locomotor
sensitization was performed as previously described.13 Spontaneous
locomotor activity was first measured (day 1), over 15min and 1 h after
a bilateral infusion of TAT-GluN1C1 or TAT-GluN1C1Δ.
Primary striatal cell cultures, immunoblots, immunocytochemistry, cyclic
AMP (cAMP) production assay and live calcium imaging were conducted as
previously described.14
Data analysis
Results are expressed as fold of control (mean± s.e.m.). ‘N’ represents the
number of independent cell culture experiments, and ‘n’ the number of
wells for a given culture or the number of mice per group. Statistical
analysis was carried out using Prism 5.0 (GraphPad, University of
Southampton, Southampton, UK). T-test, one or two-way analysis of
variance, with post hoc analysis performed where appropriate and
significance was set to Po0.05.
RESULTS
Co-stimulation of D1R and NMDAR induces D1R/GluN1 complexes
We sought to detect endogenous D1R/GluN1 complexes in their
native environment in MSN by the PLA approach. A clear punctate
signal was detectable in slices from naïve wild-type mice but not
in drd1a knockout mice (drd1a KO; Figures 1a and b). In agreement
with a strong somatic expression of both D1R and GluN1 in
cultured MSN (Supplementary Figure S1a), D1R/GluN1 complexes
were concentrated on the soma. The PLA signal was also specific
in vitro, as it disappeared if one of the two primary antibodies
was omitted (Figures 1c and d; Neg. Cont). To study whether
D1R/GluN1 complexes are regulated by glutamate and DA inputs,
cultured MSN were stimulated with glutamate (0.3 μM) or
SKF38393 (3 μM) used separately (Supplementary Figure S1b and
c), or together (Figures 1c and d and Supplementary Figure S1b
and c), a treatment hereafter referred to as co-stim. We previously
validated this co-stim model as instrumental to identify signalling
events required for cocaine-induced responses in vivo.14 MSN
co-stimulated for 10min presented significantly more D1/GluN1
complexes than controls (156 ± 12.99%, Figures 1c and d). In light
of previous studies showing that agonism at the D1R can
D1R/GluN1 interactions allow cocaine responses
E Cahill et al
1296
Molecular Psychiatry (2014), 1295 – 1304 © 2014 Macmillan Publishers Limited
decrease18 or spare17 D1R/GluN1 interaction depending on the
model used, our data further suggest that D1R/GluN1 interaction
is a fine-tuned dynamic mechanism that depends, at least in part,
on agonist binding and raise questions as to the functional
relevance of these complexes.
To interfere with D1R/GluN1 proximity, we designed a TAT-
coupled peptide corresponding to the C1 cassette (D864–T900) of
GluN1 that binds to D1R (TAT-GluN1C1, Figure 1e). This peptide
was cell-permeable and not deleterious for neuronal survival
(Supplementary Figure S2a and b). As a control peptide (TAT-
GluN1C1Δ), we eliminated nine amino acids (890SFKRRRSSK898)
that are involved in the electrostatic interaction between D1R
and GluN1 fragments in vitro.23 This strategy proved efficient and
selective as TAT-GluN1C1 blocked the increase of D1R/GluN1
complexes induced by the co-stim (169 ± 27%, Figures 1f and g),
whereas it did not significantly change D1R/GluN1 proximity
under basal conditions. The TAT-GluN1C1Δ did not prevent the
increase of D1R/GluN1 complexes induced by the co-stim (Figures
1f and g). This increase of D1R/GluN1 induced by the co-stim
in MSN pre-treated with the control TAT-GluN1C1Δ peptide
and the inhibitory effect of the TAT-GluN1C1 were confirmed
by immunoprecipitation and occurred independently on
changes of expression levels of D1R or GluN1 (Supplementary
Figure S1d).
Figure 1. Endogenous D1R/GluN1 complexes in medium spiny neurons (MSNs) are regulated by receptor co-stimulation and blocked by
TAT-GluN1C1. (a) Confocal images and (b) quantification of D1R/GluN1 complexes detected by proximity ligation assay (PLA) in the nucleus
accumben (NAc) of D1R-deficient (drd1a KO) or wild-type (WT) mice. **Po0.01; unpaired Student’s t-test, n= 4. (c) Images and
(d) quantification of proximity ligation assay (PLA) signals from cultured MSN obtained when the dopamine D1 receptor (D1R) antibody is
omitted as a negative control (Neg. Cont), or when the D1R and GluN1 antibodies are used after a 10-min incubation in the absence (Control)
or presence of 0.3 μM glutamate and 3 μM SKF38393 (Co-stim). One-way analysis of variance (ANOVA), Newman–Keuls post hoc test, *Po0.05;
***Po0.001; N= 4–5 independent experiments. (e) Amino-acid sequence of TAT-GluN1C1 and TAT-GluN1C1Δ peptides. (f) PLA images and (g)
quantifications of D1R/GluN1 complexes from MSN pre-treated with TAT-GluN1C1Δ or TAT-GluN1C1 and co-stimulated or not
one-way ANOVA, Newman–Keuls post hoc test, *Po0.05; ***Po0.001; n= 5–6; unpaired Student’s t-test. Scale bar, 10 μM.
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D1R/GluN1 complexes control D1R-mediated potentiation of
NMDAR signalling to ERK
We hypothesised that D1R/GluN1 interaction may underlie the
convergence of DA and glutamate signals onto ERK and control
striatal-dependent plasticity and behaviour. We thus evaluated
the impact of TAT-GluN1C1 on the D1R-induced potentiation of
NMDAR functions that trigger ERK activation in cultured MSNs. As
previously described,14 the combined application of individually
D1R/GluN1 interactions allow cocaine responses
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inefficient doses of glutamate and SKF38393 (co-stim) triggers
transient calcium entries that we identified here as dependent on
ifenprodil-sensitive GluN2B-NMDAR (Figure 2a). Interestingly, this
facilitation of NMDAR functions was blunted by TAT-GluN1C1,
whereas the control TAT-GluN1C1Δ peptide had no effect on
amplitude and kinetics of calcium signals (Figures 2b–d).
As we previously demonstrated that this potentiation of
NMDAR by D1R also involves a cAMP-independent phosphory-
lation of Tyr1472-GluN2B (pGluN2B),14 we further evaluated the
role of the D1R/GluN1 complexes formation in D1R-induced
phosphorylation of Tyr1472-GluN2B. Importantly, the increase of
pGluN2B-positive cells induced by the co-stim in the presence
of the control TAT-GluN1C1Δ was abrogated by TAT-GluN1C1
(Figures 2e and f). Downstream from calcium, TAT-GluN1C1
selectively blocked ERK activation induced by the receptor
co-stim (Figure 2g) in a dose-dependent manner (Supplemen-
tary Figure S2c), thus supporting that D1R/GluN1 complexes act
a molecular bridge linking DA to glutamate signalling in MSN.
Since the TAT-GluN1C1 has never been used to alter endo-
genous D1R/GluN1 complexes (see discussion), we had to exclude
the possibility that it may non-specifically interfere with D1R and/
or NMDAR signalling independently of their heteromerization.
TAT-GluNC1 binds to the t2 domain of D1R (Supplementary Figure
S3a, d), which does not overlap with the third intracellular loop
required for the positive coupling of D1R to adenylyl cyclase
activation24 and cAMP production through the Gs protein Golf.25
As expected, cAMP production induced by the co-stim was
unaffected by TAT-GluN1C1 (Figure 3a). Moreover, TAT-GluN1C1
preserved the downstream increase in Ser845 phosphorylation of
the GluA1 subunit of AMPAR (Figure 3b), a well-established target
of the D1R/cAMP/protein kinase A (PKA) cascade.26 We also
ruled out potential side effects on NMDAR signalling by showing
that glutamate-induced calcium increase and downstream
NMDAR-dependent ERK activation were unaffected by TAT-
GluN1C1 (Figures 3c–f). Disruption of D1R/GluN1 complexes
thus blocks the crosstalk linking D1R to the potentiation of
calcium influx through GluN2B-NMDAR and downstream ERK
activation, an important event for cocaine-mediated responses
in vivo.
D1R/GluN1 complexes govern long-term striatal plasticity
Given the importance of long-term plasticity at glutamatergic
synapses onto MSN for behavioural responses to cocaine, we
Figure 3. Canonical individual dopamine D1 receptor (D1R) or NMDAR signalling is preserved in presence of TAT-GluN1C1. (a) Fold increase in
cyclic AMP (cAMP) production 10min after the co-stimulation in the absence (white) or presence of TAT-GluN1C1 (black); N= 2; n= 3; one-way
analysis of variance (ANOVA), Newman–Keuls post hoc test. (b) Immunoblots and quantification of Ser845-GluA1 phosphorylation (pGluA1)
from medium spiny neurons (MSNs) co-stimulated or not in the absence (white) or presence of TAT-GluN1C1 (black); N= 5; two-way ANOVA,
Bonferroni post hoc test. (c–e). As for Figures 2b–d, but MSNs are stimulated with glutamate (10 μM). (f) Phosphorylated extracellular signal-
regulated kinase (pERK) immunoblots and quantification from cells stimulated or not with 10 μM glutamate (10 min) in the absence or
presence of TAT-GluN1C1 or MK801. N= 7–8; one-way ANOVA, Bonferroni post hoc test. (a–f) *Po0.05; ***Po0.001 (control).
Figure 2. Dopamine D1 receptor (D1R)/GluN1 complexes control D1R-mediated potentiation of NMDAR signalling to extracellular signal-
regulated kinase (ERK). (a) Calcium profiles (ΔF/F± s.e.m.) from medium spiny neurons (MSNs) treated with glutamate or SKF38393 or both
(co-stim) in the absence or presence of ifenprodil (10 μM). (b) Images of calcium signals under basal conditions (left) and at the peak response
induced by the co-stimulation in the absence (Control, top row), or presence of TAT-GluN1C1 (middle) or TAT-GluN1C1Δ (bottom). (c) Calcium
profiles and (d) corresponding area under the curves (AUC) from neurons treated co-stimulated in the absence or presence of TAT-GluN1C1
(black) or TAT-GluN1C1Δ (grey); N= 3–5, n= 72–176 cells). One-way analysis of variance (ANOVA), Bonferroni post hoc test, **Po0.01; (Control);
°°°Po0.001; (TAT-GluN1C1Δ); (e) Immunocytochemistry of phospho-Tyr1472-GluN2B (pGluN2B) and (f) percentage of pGluN2B-positive
neurons from MSNs pre-treated with TAT-GluN1C1Δ or TAT-GluN1C1 and co-stimulated or not (Control) for 10min. *Po0.05; N= 4; one-way
ANOVA, Newman–Keuls post hoc test. (g) ERK1/2 phosphorylation (pERK) measured by immunoblot from MSN co-stimulated or not in absence
(white) or presence of TAT-GluN1C1 (black) or TAT-GluN1C1Δ (grey). *Po0.05; ***Po0.001 (Control); °°°Po0.001 (co-stim); §Po0.05
(TAT-GluN1C1Δ, co-stim); N= 5; two-way ANOVA, Bonferroni post hoc test.
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Figure 4. Dopamine D1 receptor (D1R)/GluN1 complexes control long-term synaptic plasticity in D1R-medium spiny neurons (MSNs). (a)
NMDAR-mediated excitatory post synaptic currents (EPSCs) were pharmacologically isolated (blockade of AMPAR or NMDAR-EPSC by NBQX
and by AP5, respectively). (b) Example traces and quantification of AMPA/NMDAR ratio after AMPAR- and NMDAR-EPSCs were recorded
successively (before and after pharmacological isolation of the NMDAR-EPSC) in presence of GluN1C1, or GluN1C1Δ, D1-t3, RpcAMP in the
patch pipette or bath application of the GluN2B-containing NMDAR antagonist, ifendprodil (n= 6–10). Students unpaired t-test, *Po0.05
different from control (GluN1C1Δ). (c) The potentiation of NMDAR-mediated EPSCs by SKF38393 observed in the presence of GluN1C1Δ in the
internal solution is reversed by bath application of a D1R antagonist (SCH-23390 10 μM; n= 9). (d) In the presence of GluN1C1, SKF38393 no
longer potentiates NMDAR-EPSCs (n= 10). (e) Ifenprodil prevents the SKF38393-induced potentiation of NMDAR-mediated EPSCs (n= 8),
whereas the D1-t3 peptide (n= 5) has no effect (f). (g) RpcAMP partially, but significantly, alters the potentiation NMDAR-mediated EPSCs by a
D1R agonist (n= 12). (h) The D1R antagonist (SCH-23390 10 μM; n= 6) prevents high-frequency stimulation-induced (HFS, 100 Hz) long-term
potentiation (LTP) of AMPAR-EPSCs recorded in D1R-MSNs (n= 6). (i) GluN1C1 prevents HFS-LTP in D1R-MSNs (n= 12) but not in D2R-MSNs
(n= 6). (a–i) MSNs were identified using drd1a-eGFP, drd1a-tdTomato or drd2-eGFP transgenic mice. *Po0.05; Students unpaired t-test when
percent variation from baseline during the last 5 min is different from control condition. Scale bars, 10 ms, 20 pA.
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studied whether D1R/GluN1 complexes were involved in the
modulation of glutamatergic transmission in the NAc in slices
prepared from transgenic mice expressing tdTomato or the eGFP
under the control of the promoter of the drd1a gene to identify
D1R-MSN.22 D1R/GluN1 proximity did not seem primarily involved
in basal glutamatergic synaptic transmission since neither peptide
modified the AMPA/NMDA ratio (Figures 4a and b). We then
tested if D1R/GluN1 complexes are involved in the facilitation of
NMDAR-mediated EPSCs by D1R agonists.27 This appeared to be
the case since the D1R agonist-induced increase in NMDAR-EPSCs
amplitude in the presence of GluN1C1Δ in the patch pipette
(Figure 4c) was fully blocked with GluN1C1 (Figure 4d). Similarly,
to the potentiation of NMDAR-dependent calcium influx evoked
by the D1R stimulation in cultured MSN (Figure 2a), ifenprodil
blunted the D1R agonist-induced potentiation of NMDA-EPSCs,
thus supporting that D1R/GluN1 may preferentially modulate
GluN2B-containing NMDAR (Figure 4e). In agreement with this, a
peptide sequence corresponding to the binding domain of D1R to
GluN2A (D1-t3)18 had no effect on the facilitation of NMDA-EPSCs
induced by D1R stimulation (Figure 4f). To further characterize the
mechanism underlying the facilitation of NMDA currents by D1R in
our model, we also assessed the role of PKA activity downstream
from D1R. We found that the PKA inhibitor, RpcAMP, strongly
altered basal glutamatergic transmission as seen with the marked
reduction of the AMPA/NMDA ratio (Figure 4b) and partially, but
significantly, inhibited the D1R agonist-induced potentiation of
NMDA-EPSCs (Figure 4g). However, this PKA-dependent compo-
nent of the D1R-mediated NMDAR functions is unlikely to be
involved in the triggering of ERK activity downstream of both
receptors, which is a cAMP-independent event.14
With regard to long-term synaptic plasticity, high-frequency
stimulation-LTP induced in identified D1R-MSN strictly depends
on both NMDAR and ERK activation.15 Here we found that
it was abrogated by a bath application of the D1 antagonist
SCH-23390 (Figure 4h). In slices from drd1a-eGFP and drd2-eGFP
mice, high-frequency stimulation-induced LTP in both D1R-
and D2R-MSN.15 Importantly, addition of GluN1C1 in the patch
pipette selectively blunted LTP in D1R-MSN, but not in D2R-MSN
(Figure 4i). This results thus show that D1R/GluN1 interaction
controls a ERK-dependent synaptic plasticity in D1R-MSN
specifically.
D1R/GluN1 complexes in the NAc control cocaine-induced
adaptation in vivo
To examine whether D1R/GluN1 complexes have a functional
relevance in vivo, we infused unilaterally TAT-GluN1C1 into the
NAc of mice and found it significantly lowered the number of
pERK-positive cells induced by cocaine when compared with the
contra-lateral NAc (Figures 5a and b).
As a causal connection between cocaine-evoked ERK activation,
synaptic potentiation and behaviour has been established for
locomotor sensitization,12,15 we investigated the impact of a
bilateral infusion of TAT-GluN1C1 or TAT-GluN1C1Δ into the NAc
using the two-injection protocol of sensitization13 (Figure 5c). In
both groups of mice, basal locomotor activity (Figure 5d) and
acute increase in activity induced by a single cocaine injection
(Figures 5e and f; cocaine Inj.1) were not statistically different.
Mice received a second injection of cocaine at day 8 and the TAT-
GluN1C1Δ pre-treated mice showed a clear behavioural sensitiza-
tion. In contrast, the TAT-GluN1C1-pre-treated group did not show
any significant increase in their locomotor activity when compar-
ing day 1 and day 8 (Figures 5f and g). Therefore the dissociation
of D1R/GluN1 interactions remarkably prevents the development
of psychomotor sensitization to cocaine but not basal locomotion
or acute responses to cocaine.
DISCUSSION
This work provides evidence on multiple levels that dynamic
associations between D1R and GluN1 are involved in signalling,
plasticity and behaviour that model early phases of cocaine
addiction. A selective inhibition of D1R/GluN1 complexes is
possible without compromising the functions of individual D1R
and NMDAR, which possibly avoids the caveat of frequent side
effects encountered due to global blockade of either given
receptor subtype.
The strategy we used to block D1R/GluN1 proximity fundamen-
tally also tells us more about the mechanisms involved in D1R/
GluN1 interaction, as it confirmed a physiological relevance of the
Arg-rich epitope in C1, as predicted by Woods et al.23 in vitro, but
here in the receptor’s native environment. This epitope shares
remarkable similarities with the Arg-rich epitope involved in
physical interactions of D2R with Adenosine A2 receptors,28 which
suggests that conserved electrostatic interactions may be
involved. We chose to use the full-length C1 cassette sequence,
the TAT-GluN1C1 peptide, to gain more specificity in targeting
D1R/GluN1 complexes and to compare our data with previous
studies. However, we did test a peptide containing only the Arg-
rich epitope (TAT-GluN1C1-min) and found it was sufficient to
block ERK activation by receptor co-stim (Supplementary Figure
S3a, c, f). Importantly, previous studies have used the comple-
mentary interaction site to design interfering peptides.20 This site
corresponds to the sequence of the D1RcT that binds to GluN1
(TAT-D1-t2). When we tested the TAT-Dt-2, it tended to increase
basal ERK activity (N= 4; P= 0.055; Supplementary Figure S3a, d, g).
This surprising impact on NMDAR-dependent signalling to ERK
may result from a competition between TAT-D1-t2 and GluN1 for
binding to Calmodulin18,29 but requires further investigation.
Likewise, the peptide TAT-D1-t3, which prevents D1R binding to
the GluN2A subunit, did not block ERK activation by co-stim of
NMDAR and D1R (Supplementary Figure S3a, e, h), which is
agreement with its lack of effect on D1R-induced facilitation of
NMDA-EPSCs (Figure 4f). While other binding partners of the
C-terminal domains of D1R and NMDAR probably also contribute
to the processes we examine herein, no other known partner
could reproduce the observed effects here on the multiple levels
and different readouts. Such partners include the aforementioned
calmodulin; however, interference with this interaction would
likely prolong or enhance NMDAR signalling, opposite to what
we observe for TAT-GluN1C1, and this site has a low affinity in
comparison with the binding domain in C1.29 Other known
partners of the C1 domain of the GluN1 subunit include
scaffolding proteins, such as yaotiao, neurofilaments and
microtubules.30 As our electrophysiology results showed no
change in NMDAR current at basal levels (Figure 4), there is
ample reason to doubt that TAT-GluN1C1 is sufficient to perturb
the trafficking of NMDAR guided by these scaffold protein
interactions. As for the D1R C-terminal partners, TAT-GluN1C1
could possibly compete with PSD-95 for its binding to D1R;
however, we did not see any change in cAMP production (Figures
3a and b), which suggests that D1R remains expressed at the
surface and capable of signalling. The region of interaction with
PSD-95 may well rather depend on the D1-t1 or D1-t3 regions
(and not D1-t2 which is examined here). The t2 domain of D1R
also interacts with N-ethylmaleimide-sensitive factor.31 N-ethyl-
maleimide-sensitive factor is a hexametric ATPase studied for its
functions in membrane trafficking and endocytosis. Interfering
with this interaction blocked D1R membrane localisation and
inhibited D1R-mediated cAMP production, which was not
observed in the present study. Altogether, our data support the
idea that the strategy we chose to disrupt D1R/GluN1 complexes
with TAT-GluN1 does not drastically alter the coupling of D1R
and NMDAR to their cognate signalling partners, but specifically
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impact the interplay between D1R and NMDAR-dependent
signalling.
The D1R/NMDAR interplay is critical for striatal signalling and
plasticity.32 An important mechanism for this dialogue between
both receptors involved a D1R-mediated phosphorylation of
GluN2B that is important for cocaine-induced signalling and
behaviour.14 The fact that TAT-GluN1C1 blocked (1) the phos-
phorylation of GluN2B, (2) the potentiation of NMDAR-EPSCs; (3)
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the potentiation of NMDAR–calcium influx by D1R and (4) ERK
activation downstream of both receptors supports the idea that
D1R/GluN1 interaction has a gating function for the facilitation of
NMDAR-dependent calcium influx triggering ERK activation in
response to D1R stimulation.
The observation that TAT-GluN1C1 spared the canonical cAMP/
PKA pathway downstream from D1R is in agreement with
previous work in cell lines overexpressing D1R and GluN1 where
disruption of their interaction did not modify D1R-induced cAMP
production per se, but rather its potentiation by NMDA,19 a
phenomenon that we did not observe in our system (data not
shown). It is also in favour of an uncoupling between cAMP/PKA
and ERK activation in MSN that could account for the preserved
ERK phosphorylation by psychostimulants seen previously in mice
deficient for the Gαolf/cAMP/PKA pathway
33 (Gnal+/− ). We thus
propose that a trigger for ERK activation relies on D1R/GluN1
complexes that recruit D1R-mediated signalling onto GluN2B and
promotes calcium influx. The duration and amplitude of ERK
activation would then be modulated by the D1R/cAMP/PKA
cascade via DARPP-32 and inhibition of phosphatases targeting
the ERK pathway.34
A causal link between ERK activation, long-term synaptic
plasticity in D1R-MSNs and behavioural responses to cocaine has
recently been established. A single cocaine injection indeed
triggers a potentiation of AMPAR-mediated EPSCs in D1R-MSN
and optogenetically induced depotentiation of these excitatory
inputs onto MSN abolishes locomotor sensitization to cocaine.15
Herein, we established that D1R/GluN1 complexes control the
integration of DA and glutamate inputs by MSN, long-term
synaptic plasticity and locomotor sensitization to cocaine. Genetic
or pharmacological inhibition of GluN2B and GluN2A has been
shown to differentially alter the potentiation of NMDAR by a D1R
agonist in MSN. Whereas GluN2A knockout mice showed a higher
potentiation of NMDAR-EPSCs by D1R, pharmacological inhibition
of GluN2B drastically inhibited this facilitation.35 The demonstra-
tion here that D1R/GluN1 complexes are necessary both for the
phosphorylation of GluN2B (Figures 2e and f) and the facilitation
of ifenprodil-sensitive NMDAR-EPSCs (Figures 4d and e), strongly
argues in favour of a privileged role of these complexes in the
D1R-mediated potentiation of GluN2B-NMDAR in MSN.
Although further studies will be required to determine whether
the synergistic effect of D1R/NMDAR interaction on signalling
results from crosstalk or oligomerization,36 a growing body of
evidences suggests that oligomerization can affect activity or
signalling but also the binding properties of receptors.37 A better
understanding of the nature of D1R/NMDAR interaction could
open new routes toward the development of more specific
ligands that could selectively target D1R/NMDAR complexes. Our
results highlight the potential for future research to target D1R/
NMDAR complexes as a valuable therapeutic approach in drug
addiction.
By contrast to the mechanism of D1R-mediated potentiation of
NMDAR functions through D1R/GluN1 oligomers we describe
here, cocaine was previously shown to induce D2R/GluN2B
oligomer formation, which reduced NMDAR-mediated currents.38
In the striatum, the association between the third intracellular
loop of the D2R and the carboxyl terminal tail of GluN2B was
enhanced by cocaine. The binding of D2R to the GluN2B displaces
CaMKII and reduces GluN2B phosphorylation at Ser1303 as well as
calcium currents. Furthermore, this interaction was shown to have
functional consequences as a TAT-coupled peptide that mimicked
the D2R region of interaction prevented acute horizontal activity
and stereotyped behaviour normally induced by high doses of
cocaine. However, the role of D2R/GluN2B complexes in the
development of behavioural sensitization to cocaine is not yet
defined. The fine tuning of DA and glutamate crosstalk achieved
by receptor complexes should thus be a novel consideration for
understanding the pathophysiology of the vast spectrum of
psychiatric disorders associated with improper dopaminergic
modulation of glutamate transmission in brain regions where
the existence of D1R/GluN1 complexes is strongly supported.39
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